CANDIDO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 2.945
EU - Europa 1.652
AS - Asia 1.077
SA - Sud America 219
AF - Africa 164
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.061
Nazione #
US - Stati Uniti d'America 2.860
IT - Italia 682
SG - Singapore 586
IE - Irlanda 382
CN - Cina 352
BR - Brasile 207
UA - Ucraina 196
DE - Germania 138
CI - Costa d'Avorio 108
CA - Canada 79
RU - Federazione Russa 79
VN - Vietnam 59
SN - Senegal 36
FI - Finlandia 29
SE - Svezia 28
IN - India 21
FR - Francia 20
NL - Olanda 20
CH - Svizzera 17
GB - Regno Unito 17
AT - Austria 11
NG - Nigeria 8
TR - Turchia 8
UZ - Uzbekistan 8
IQ - Iraq 7
IR - Iran 7
PK - Pakistan 7
AR - Argentina 6
BD - Bangladesh 5
GR - Grecia 5
PL - Polonia 5
ZA - Sudafrica 5
BE - Belgio 4
BG - Bulgaria 4
RO - Romania 4
AU - Australia 3
KZ - Kazakistan 3
LB - Libano 3
MX - Messico 3
TN - Tunisia 3
AL - Albania 2
CZ - Repubblica Ceca 2
IL - Israele 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
KE - Kenya 1
LI - Liechtenstein 1
MA - Marocco 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
TW - Taiwan 1
Totale 6.061
Città #
Santa Clara 645
Chandler 420
Dublin 375
Singapore 337
Jacksonville 277
Chicago 210
Catania 199
Boardman 151
Abidjan 108
Cambridge 100
Lawrence 100
Andover 91
Grafing 84
Nanjing 82
Toronto 68
Houston 56
Des Moines 55
Wilmington 52
Ashburn 47
Dong Ket 47
Civitanova Marche 43
Dakar 36
San Mateo 30
Council Bluffs 27
Hebei 27
Beijing 26
Nanchang 25
Palermo 25
Helsinki 23
Saint Petersburg 22
Rome 19
Shenyang 19
São Paulo 18
Jiaxing 16
Falls Church 14
Bremen 13
Dearborn 12
Hanoi 12
Naples 12
Padova 12
Acireale 11
Ottawa 11
Rio de Janeiro 10
Milan 9
Redwood City 9
Tianjin 9
Abuja 8
Aci Catena 8
Augusta 8
Jinan 8
Los Angeles 8
Mascalucia 8
Norwalk 8
Changsha 7
Guangzhou 7
Leawood 7
The Dalles 7
Belo Horizonte 6
Den Haag 6
Frankfurt Am Main 6
Lappeenranta 6
Redmond 6
Amsterdam 5
Ardabil 5
Maletto 5
Misterbianco 5
Mumbai 5
Munich 5
Ningbo 5
Vasto 5
Baghdad 4
Bari 4
Brussels 4
Cape Town 4
Edinburgh 4
Kunming 4
Nuremberg 4
Syracuse 4
Tremestieri Etneo 4
Turin 4
Zhengzhou 4
Ann Arbor 3
Capo D'orlando 3
Florence 3
Florianópolis 3
Fortaleza 3
Genoa 3
Guarulhos 3
Hangzhou 3
Messina 3
Moscow 3
New York 3
Porto Alegre 3
Pune 3
Rosolini 3
San Diego 3
San Francisco 3
San Giovanni la Punta 3
Seattle 3
Serra 3
Totale 4.249
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 191
Computational modelling in melanoma for novel drug discovery 95
Prognostic significance of deregulated microRNAs in uveal melanomas 91
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 89
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 85
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 83
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 82
Environment and bladder cancer: Molecular analysis by interaction networks 82
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 81
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 81
Cutaneous melanoma: From pathogenesis to therapy 81
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 80
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 78
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 77
Nitric Oxide in Hematological Cancers: Partner or Rival? 77
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 77
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 76
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 76
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 76
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 75
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 75
microRNAs and thyroid cancer: Biological and clinical significance (Review). 73
Advances in targeting signal transduction pathways. 72
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 72
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 71
Pericytes in microvessels: From “mural” function to brain and retina regeneration 70
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 69
Emerging targeted therapies for melanoma treatment (review) 69
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 68
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 67
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 66
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 64
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 63
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 63
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 61
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 61
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 61
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 60
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 60
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 60
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 59
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 59
Cutaneous melanoma and the immunotherapy revolution (Review) 59
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 58
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 58
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 58
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 56
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 54
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 54
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 54
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 54
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 53
Targeting signaling pathways involved in metastasis in cancer stem cells 52
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 52
Suppressing prostate cancer by targeting NGAL 51
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 50
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 50
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 50
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 49
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 49
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 48
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 48
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 47
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 47
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 46
The tumor microenvironment in hepatocellular carcinoma 46
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 45
Cancer therapy and treatments during COVID-19 era 45
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 44
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 44
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 43
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 43
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways 43
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 42
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 42
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 42
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 42
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 42
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 40
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 40
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 40
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 40
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 40
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 40
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 40
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 40
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 40
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 39
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 39
MMP-9 is down-regulated after treatment with Vemurafenib in A375 and A2058 melanoma cells 39
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 39
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 38
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 37
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 37
Neopterin: a potential marker in chronic peripheral arterial disease. 37
Metformin influences drug sensitivity in pancreatic cancer cells 37
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 37
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 37
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy 35
Molecular Targeted Therapy In Melanoma: A Way To Reverse Resistance To Conventional Drugs. 35
Totale 5.782
Categoria #
all - tutte 25.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 0 0 0 0 35 15
2020/2021623 8 31 62 4 107 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.288 24 390 143 142 589 286 131 103 210 266 4 0
Totale 6.252